Breast Cancer Subtypes and the Risk of Local and Regional Relapse

作者: K. David Voduc , Maggie C.U. Cheang , Scott Tyldesley , Karen Gelmon , Torsten O. Nielsen

DOI: 10.1200/JCO.2009.24.9284

关键词:

摘要: Purpose The risk of local and regional relapse associated with each breast cancer molecular subtype was determined in a large cohort patients cancer. Subtype assignment accomplished using validated six-marker immunohistochemical panel applied to tissue microarrays. Patients Methods Semiquantitative analysis estrogen receptor (ER), progesterone (PR), Ki-67, human epidermal growth factor 2 (HER2), (EGFR), cytokeratin (CK) 5/6 performed on microarrays constructed from 2,985 early invasive were classified into the following categories: luminal A, B, luminal-HER2, HER2 enriched, basal-like, or triple-negative phenotype‐nonbasal. Multivariable Cox used determine intrinsic subtypes, adjusting for standard clinicopathologic factors. Results successfully tumors. median follow-up time 12 years, there have been total 325 recurrences 227 lymph node recurrences. Luminal A tumors (ER PR positive, negative, Ki-67 14%) had best prognosis lowest rate relapse. For undergoing conservation, HER2-enriched basal subtypes demonstrated an increased recurrence, this statistically significant multivariable analysis. After mastectomy, HER2-enriched, all

参考文章(42)
Michelle K Nottage, Karen A Kopciuk, Anjela Tzontcheva, Irene L Andrulis, Shelley B Bull, Martin E Blackstein, Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: A prospective cohort study Breast Cancer Research. ,vol. 8, pp. 1- 10 ,(2006) , 10.1186/BCR1531
Laura G Fulford, Jorge S Reis-Filho, Ken Ryder, Chris Jones, Cheryl E Gillett, Andrew Hanby, Douglas Easton, Sunil R Lakhani, Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Breast Cancer Research. ,vol. 9, pp. 1- 11 ,(2007) , 10.1186/BCR1636
Gabriele Martelli, Rosalba Miceli, Aurora Costa, Danila Coradini, Stefano Zurrida, Domenico Piromalli, Gaetano Vetrella, Marco Greco, Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study. Cancer. ,vol. 112, pp. 481- 488 ,(2008) , 10.1002/CNCR.23213
Rinaa S. Punglia, Monica Morrow, Eric P. Winer, Jay R. Harris, Local Therapy and Survival in Breast Cancer The New England Journal of Medicine. ,vol. 356, pp. 2399- 2405 ,(2007) , 10.1056/NEJMRA065241
Tina J. Hieken, Miguel Farolan, Stephen D'Alessandro, Josè M. Velasco, Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers. Surgery. ,vol. 130, pp. 593- 601 ,(2001) , 10.1067/MSY.2001.116921
Bruce G. Haffty, Analene Hauser, Doo Ho Choi, Nicole Parisot, David Rimm, Bonnie King, Darryl Carter, Molecular markers for prognosis after isolated postmastectomy chest wall recurrence. Cancer. ,vol. 100, pp. 252- 263 ,(2004) , 10.1002/CNCR.11915
M I Koukourakis, , A Giatromanolaki, G Galazios, E Sivridis, Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference? British Journal of Cancer. ,vol. 88, pp. 711- 717 ,(2003) , 10.1038/SJ.BJC.6600755
Joseph Ragaz, Stewart M. Jackson, Nhu Le, Ian H. Plenderleith, John J. Spinelli, Vivian E. Basco, Kenneth S. Wilson, Margaret A. Knowling, Christopher M.L. Coppin, Marilyn Paradis, Andrew J. Coldman, Ivo A. Olivotto, Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer The New England Journal of Medicine. ,vol. 337, pp. 956- 962 ,(1997) , 10.1056/NEJM199710023371402